228 related articles for article (PubMed ID: 26075792)
1. An in vivo screen identifies ependymoma oncogenes and tumor-suppressor genes.
Mohankumar KM; Currle DS; White E; Boulos N; Dapper J; Eden C; Nimmervoll B; Thiruvenkatam R; Connelly M; Kranenburg TA; Neale G; Olsen S; Wang YD; Finkelstein D; Wright K; Gupta K; Ellison DW; Thomas AO; Gilbertson RJ
Nat Genet; 2015 Aug; 47(8):878-87. PubMed ID: 26075792
[TBL] [Abstract][Full Text] [Related]
2. Integrative genomics identified RFC3 as an amplified candidate oncogene in esophageal adenocarcinoma.
Lockwood WW; Thu KL; Lin L; Pikor LA; Chari R; Lam WL; Beer DG
Clin Cancer Res; 2012 Apr; 18(7):1936-46. PubMed ID: 22328562
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic genome-wide analysis identifies BEX1 as a candidate tumour suppressor gene in paediatric intracranial ependymoma.
Karakoula K; Jacques TS; Phipps KP; Harkness W; Thompson D; Harding BN; Darling JL; Warr TJ
Cancer Lett; 2014 Apr; 346(1):34-44. PubMed ID: 24333734
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic targeting of ependymoma as informed by oncogenic enhancer profiling.
Mack SC; Pajtler KW; Chavez L; Okonechnikov K; Bertrand KC; Wang X; Erkek S; Federation A; Song A; Lee C; Wang X; McDonald L; Morrow JJ; Saiakhova A; Sin-Chan P; Wu Q; Michaelraj KA; Miller TE; Hubert CG; Ryzhova M; Garzia L; Donovan L; Dombrowski S; Factor DC; Luu B; Valentim CLL; Gimple RC; Morton A; Kim L; Prager BC; Lee JJY; Wu X; Zuccaro J; Thompson Y; Holgado BL; Reimand J; Ke SQ; Tropper A; Lai S; Vijayarajah S; Doan S; Mahadev V; Miñan AF; Gröbner SN; Lienhard M; Zapatka M; Huang Z; Aldape KD; Carcaboso AM; Houghton PJ; Keir ST; Milde T; Witt H; Li Y; Li CJ; Bian XW; Jones DTW; Scott I; Singh SK; Huang A; Dirks PB; Bouffet E; Bradner JE; Ramaswamy V; Jabado N; Rutka JT; Northcott PA; Lupien M; Lichter P; Korshunov A; Scacheri PC; Pfister SM; Kool M; Taylor MD; Rich JN
Nature; 2018 Jan; 553(7686):101-105. PubMed ID: 29258295
[TBL] [Abstract][Full Text] [Related]
5. Oncogenes without a Neighboring Tumor-Suppressor Gene Are More Prone to Amplification.
Wu WK; Li X; Wang X; Dai RZ; Cheng AS; Wang MH; Kwong T; Chow TC; Yu J; Chan MT; Wong SH
Mol Biol Evol; 2017 Apr; 34(4):903-907. PubMed ID: 28087780
[TBL] [Abstract][Full Text] [Related]
6. Supratentorial and spinal pediatric ependymomas display a hypermethylated phenotype which includes the loss of tumor suppressor genes involved in the control of cell growth and death.
Rogers HA; Kilday JP; Mayne C; Ward J; Adamowicz-Brice M; Schwalbe EC; Clifford SC; Coyle B; Grundy RG
Acta Neuropathol; 2012 May; 123(5):711-25. PubMed ID: 22109108
[TBL] [Abstract][Full Text] [Related]
7. Array CGH identifies distinct DNA copy number profiles of oncogenes and tumor suppressor genes in chromosomal- and microsatellite-unstable sporadic colorectal carcinomas.
Lassmann S; Weis R; Makowiec F; Roth J; Danciu M; Hopt U; Werner M
J Mol Med (Berl); 2007 Mar; 85(3):293-304. PubMed ID: 17143621
[TBL] [Abstract][Full Text] [Related]
8. Focal chromosomal copy number aberrations identify CMTM8 and GPR177 as new candidate driver genes in osteosarcoma.
Both J; Krijgsman O; Bras J; Schaap GR; Baas F; Ylstra B; Hulsebos TJ
PLoS One; 2014; 9(12):e115835. PubMed ID: 25551557
[TBL] [Abstract][Full Text] [Related]
9. Candidate luminal B breast cancer genes identified by genome, gene expression and DNA methylation profiling.
Cornen S; Guille A; Adélaïde J; Addou-Klouche L; Finetti P; Saade MR; Manai M; Carbuccia N; Bekhouche I; Letessier A; Raynaud S; Charafe-Jauffret E; Jacquemier J; Spicuglia S; de The H; Viens P; Bertucci F; Birnbaum D; Chaffanet M
PLoS One; 2014; 9(1):e81843. PubMed ID: 24416132
[TBL] [Abstract][Full Text] [Related]
10. Pitfalls in experimental designs for characterizing the transcriptional, methylational and copy number changes of oncogenes and tumor suppressor genes.
Zhang Y; Xia J; Zhang Y; Qin Y; Yang D; Qi L; Zhao W; Wang C; Guo Z
PLoS One; 2013; 8(3):e58163. PubMed ID: 23472150
[TBL] [Abstract][Full Text] [Related]
11. Identification of tumor-specific molecular signatures in intracranial ependymoma and association with clinical characteristics.
Modena P; Lualdi E; Facchinetti F; Veltman J; Reid JF; Minardi S; Janssen I; Giangaspero F; Forni M; Finocchiaro G; Genitori L; Giordano F; Riccardi R; Schoenmakers EF; Massimino M; Sozzi G
J Clin Oncol; 2006 Nov; 24(33):5223-33. PubMed ID: 17114655
[TBL] [Abstract][Full Text] [Related]
12. Identification of gains on 1q and epidermal growth factor receptor overexpression as independent prognostic markers in intracranial ependymoma.
Mendrzyk F; Korshunov A; Benner A; Toedt G; Pfister S; Radlwimmer B; Lichter P
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2070-9. PubMed ID: 16609018
[TBL] [Abstract][Full Text] [Related]
13. Integration of DNA copy number alterations and transcriptional expression analysis in human gastric cancer.
Fan B; Dachrut S; Coral H; Yuen ST; Chu KM; Law S; Zhang L; Ji J; Leung SY; Chen X
PLoS One; 2012; 7(4):e29824. PubMed ID: 22539939
[TBL] [Abstract][Full Text] [Related]
14. Metastasizing anaplastic ependymoma in an adult. Chromosomal imbalances, metabolic and gene expression profiles.
Lopez-Gines C; Gil-Benso R; Faus C; Monleon D; Mata M; Morales JM; Cigudosa JC; Gonzalez-Darder J; Celda B; Cerda-Nicolas M
Histopathology; 2009 Mar; 54(4):500-4. PubMed ID: 19309408
[No Abstract] [Full Text] [Related]
15. A prognostic gene expression signature in infratentorial ependymoma.
Wani K; Armstrong TS; Vera-Bolanos E; Raghunathan A; Ellison D; Gilbertson R; Vaillant B; Goldman S; Packer RJ; Fouladi M; Pollack I; Mikkelsen T; Prados M; Omuro A; Soffietti R; Ledoux A; Wilson C; Long L; Gilbert MR; Aldape K;
Acta Neuropathol; 2012 May; 123(5):727-38. PubMed ID: 22322993
[TBL] [Abstract][Full Text] [Related]
16. Distinct and competitive regulatory patterns of tumor suppressor genes and oncogenes in ovarian cancer.
Zhao M; Sun J; Zhao Z
PLoS One; 2012; 7(8):e44175. PubMed ID: 22952919
[TBL] [Abstract][Full Text] [Related]
17. Expression alterations define unique molecular characteristics of spinal ependymomas.
Lourdusamy A; Rahman R; Grundy RG
Oncotarget; 2015 Aug; 6(23):19780-91. PubMed ID: 25909290
[TBL] [Abstract][Full Text] [Related]
18. Oncogenes and tumour suppressor genes in transgenic mouse models of neoplasia.
Fowlis DJ; Balmain A
Eur J Cancer; 1993; 29A(4):638-45. PubMed ID: 8435223
[No Abstract] [Full Text] [Related]
19. Heterogeneity within the PF-EPN-B ependymoma subgroup.
Cavalli FMG; Hübner JM; Sharma T; Luu B; Sill M; Zapotocky M; Mack SC; Witt H; Lin T; Shih DJH; Ho B; Santi M; Emery L; Hukin J; Dunham C; McLendon RE; Lipp ES; Gururangan S; Grossbach A; French P; Kros JM; van Veelen MC; Rao AAN; Giannini C; Leary S; Jung S; Faria CC; Mora J; Schüller U; Alonso MM; Chan JA; Klekner A; Chambless LB; Hwang EI; Massimino M; Eberhart CG; Karajannis MA; Lu B; Liau LM; Zollo M; Ferrucci V; Carlotti C; Tirapelli DPC; Tabori U; Bouffet E; Ryzhova M; Ellison DW; Merchant TE; Gilbert MR; Armstrong TS; Korshunov A; Pfister SM; Taylor MD; Aldape K; Pajtler KW; Kool M; Ramaswamy V
Acta Neuropathol; 2018 Aug; 136(2):227-237. PubMed ID: 30019219
[TBL] [Abstract][Full Text] [Related]
20. Characterization of novel and complex genomic aberrations in glioblastoma using a 32K BAC array.
Nord H; Hartmann C; Andersson R; Menzel U; Pfeifer S; Piotrowski A; Bogdan A; Kloc W; Sandgren J; Olofsson T; Hesselager G; Blomquist E; Komorowski J; von Deimling A; Bruder CE; Dumanski JP; Díaz de Ståhl T
Neuro Oncol; 2009 Dec; 11(6):803-18. PubMed ID: 19304958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
